International Journal Of Drug Delivery Technology
Volume 16, Issue 12s, 2026 | PG 6-10

A Randomized Comparative Clinical Study To Evaluate The Efficacy Of Arjuna Lepa And Manjistha Lepa In The Management Of Vyanga

Priyanka Kumari1, Gajendra Kumar Dubey2, Bhanu Pratap Singh3, Balaji Thakur4

1Assistant Professor, PG Department of Kriya Sharir, Post Graduate Institute of Ayurveda, DSRRAU, Jodhpur, Rajasthan, India. Email: priyankaloyal09@gmail.com

2Associate Professor, PG Department of Swasthavritta and Yoga, Post Graduate Institute of Ayurveda, DSRRAU, Jodhpur, Rajasthan, India

3Assistant Professor, PG Department of Kriya Sharir, National Institute of Ayurveda, Jaipur, Rajasthan, India

4Medical Officer, Bhadrak, Odisha, India. Email: balajithakur92@gmail.com


ABSTRACT

Skin reflects the beauty of healthy individuals. Today, cosmetics have become essential part of our daily routine but natural beauty is getting spoiled because of the harmful chemicals in some cosmetics. Thus, the demand of herbal product is increasing globally in cosmetic field. The concept of Varna dealt in Ayurveda is an innate entity of beauty. Melasma is the skin disease which have high prevalence rate of 1.5% to 33.3%. Lohita is the site for Vyanga which is one of the Kshudra Roga, characterized by Niruja (painless), Shyava Varna Mandala (bluish black patches) occurring especially on the face. On the basis of clinical features, it is correlated with melasma or facial melanosis, one of the hyperpigmented disorders. In modern medical science, topical steroids have been described in the management of fascial melanosis. However, the topical steroids are not completely free from adverse effects such as irritation, rashes. Hence there is a need to search better methods of management in Vyanga.

Key words- Arjuna, Manjistha, Lepa, Vyanga, Lohita, Twak, Bhrajak Pitta

How to cite this article: Kumari P, Dubey GK, Singh BP, Thakur B. A randomized comparative clinical study to evaluate the efficacy of Arjuna Lepa and Manjistha Lepa in the management of Vyanga. Int J Drug Deliv Technol. 2026;16(12s): 6-10. DOI: 10.25258/ijddt.16.12s.2

Source of support: Nil.

Conflict of interest: None